Thursday, 02 April 2020

Drug Discovery News

  • Singapore's first flu vaccine clears phase I trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2014

    Singapore: Influenza vaccine (gH1-Qbeta) developed by Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology has met its primary end point fo...Read more

  • Exjade gets FDA nod for iron overload treatment

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Jan, 2013

    Singapore: The US FDA has approved Exjade (deferasirox) for the treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia (NTDT) s...Read more

  • Customized treatments to dominate oncology therapy

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2012

    Singapore: Cancer treatments are becoming increasingly personalized, as regulators are approving therapeutics offering significant benefits to small target populations, according to a new r...Read more

  • GSK, Theravance seek EU nod for COPD drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jan, 2013

    Singapore: GlaxoSmithKline (GSK) and Theravance submitted a regulatory application in the European Union for the investigational once-daily LAMA/LABA combination medicine, UMEC/VI, for pati...Read more

  • Role of oxidative stress in autism disorder found

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

    Singapore: In an effort to explore biological influences on the varying appearance of autism spectrum disorder (ASD), Dr Pat Levitt of Saban Research Institute of Children's Hospital Los An...Read more

  • CSL Behring progresses on novel drug for Hemophilia A

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2013

    ‎Singapore: Australia-based CSL Behring achieved improved pharmacokinetic results for its novel investigational recombinant coagulation single-chain factor VIII (rVIII-SingleChain) ov...Read more

  • Sanofi begins biopharmaceutical plant construction

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2014

    Singapore: Sanofi and US-based Transgene have launched the construction phase of the manufacturing platform dedicated to the production of viral vectors, such as Transgene's MUC1 targeted c...Read more

  • Allied abdominal hernia study shows +ve results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2013

    Singapore: Allied Healthcare has achieved positive results in the study of Adapt-treated tissue as a bioprosthetic substitute for abdominal hernia repairs as well as pelvic floor reconstruc...Read more

  • Biotron's HIV drug candidate reverses impaired immune system

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2014

    Singapore: Australia based Biotron's HIV drug candidate BIT225 has demonstrated its ability to reverse HIV-induced impairment of the immune system in HIV-infected subjects. HIV infection c...Read more

  • GRPE elements to help cure HIV via gene therapy

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Apr, 2013

    Singapore: A research team from Case Western Reserve University School of Medicine has discovered an approach that could make gene therapy dramatically more effective for patients.Led by pr...Read more

  • Charles River manages 2.9% growth in Q2, 2013

    Drug Discovery |  Company results | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: Drug development company Charles River Laboratories has marked net sales of $292.9 million in the second quarter of 2013, maintaining growth of 2.9 percent from $284.7 million in...Read more

  • Coherus starts ph3 trial of rheumatoid arthritis biosimilar drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    ‎Singapore: US based biosimilar therapeutic developer, Coherus BioSciences, has started its Phase 3 trial of CHS-0214, an investigational etanercept biosimilar for rheumatoid arthriti...Read more

  • Study: Novartis' Afinitor hinders kidney tumor

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jan, 2013

    Singapore: A phase III study conducted at the Cincinnati Children's Hospital Medical Center, US, has revealed that patients, who were suffering from non-cancerous kidney tumors or renal an...Read more

  • Concert Pharma, Celgene enter in $300 mn merger

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2013

    Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deuterium-modified compounds targeting cancer and inflammation. The colla...Read more

  • Mother's antibodies may cause autism

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

    Singapore: Researchers at University of California have found that prenatal exposure to specific combinations of antibodies found only in mothers of children with autism leads to changes in...Read more

  • CellSeed withdraws stem cell drug application

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2013

    Singapore: Europe's CellSeed has withdrawn its application for a centralized marketing authorization for the medicine OraNera (autologous oral mucosal epithelial cells), a living tissue equ...Read more

  • Biodiem develops killer for drug-resistant microbes

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Oct, 2012

    Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial compound with broad-spectrum activity named BDM-I. The compound has ...Read more

  • Afatinib proves efficacy in lung cancer treatment

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

    Singapore: The LUX-Lung 3 Phase III results showed that lung cancer patients taking the novel compound afatinib, an irreversible ErbB Family Blocker, as a first-line treatment lived for alm...Read more